Omega Healthcare Investors OHI Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Omega Healthcare Investors in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Omega Healthcare Investors’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Omega Healthcare Investors's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Omega Healthcare Investors's cash & equivalents?
- Omega Healthcare Investors (OHI) reported cash & equivalents of $26.15M in Q1 2026.
- How has Omega Healthcare Investors's cash & equivalents changed year-over-year?
- Omega Healthcare Investors's cash & equivalents decreased by 92.9% year-over-year, from $367.96M to $26.15M.
- What is the long-term trend for Omega Healthcare Investors's cash & equivalents?
- Over 5 years (2020 to 2025), Omega Healthcare Investors's cash & equivalents has grown at a -30.2% compound annual growth rate (CAGR), from $163.54M to $27.02M.
- What does cash & equivalents mean?
- Cash and highly liquid assets that can be accessed immediately.
- How do you interpret cash & equivalents?
- Higher levels provide greater financial cushion and acquisition capacity, while excessively low levels may signal liquidity constraints.
- How does cash & equivalents compare across companies?
- Standard metric for all public companies; peers maintain varying levels based on their capital expenditure plans and debt maturity profiles.